President Trump is described as symptom-free, but experts question the significance of his antibody test results. Dr. Deepta Bhattacharya, an immunologist at the University of Arizona College of Medicine said the results shared by White House physician Dr. Sean P. Conley wouldn’t shed much light on Mr. Trump’s condition. “The way that it’s implied is that he’s made a normal immune response, but I don’t see how you would be able to tell the difference.”

Coronavirus could go on undetected for some people. As the President of America reportedly has 'no symptoms' after falling ill, scientists discover how the disease may dull the senses. In October 2020, researchers from the University of Arizona Health Sciences revealed coronavirus is capable of dulling pain pathways. The study is published in the journal Pain.

The Phoenix VA Health Care System Research Space will be an incubator for medical discovery, new technologies and clinical care on the Phoenix Biomedical Campus in downtown Phoenix in partnership with the University of Arizona College of Medicine – Phoenix.

University of Arizona Cancer Center researcher Dr. Daniel Persky led a study that found many patients with the most common type of non-Hodgkin’s lymphoma, diffuse large B-cell lymphoma (DLBCL), can safely skip radiation and receive fewer chemotherapy treatments.

Doctors are saying that the president is doing extremely well after being hospitalized with COVID-19 over the weekend. Dr. Shad Marvasti, of the University of Arizona College of Medicine – Phoenix, on what we are hearing about the president’s condition. Air time: 10:19 PM

Scientists at the University of Arizona Health Sciences say the virus that causes COVID-19 may have a surprising ability to relieve pain. Laboratory experiments with rodents show when the virus enters the body by binding to a gateway protein called neuropilin, it blocks the first step in the pathway that causes pain. That might explain why so many people diagnosed with COVID-19 don’t feel any symptoms. KNAU spoke with the study’s senior author Dr. Rajesh Khanna from the UArizona College of Medicine, about his findings.

The University of Arizona is launching a $7.7 million yearlong study funded by the U.S. Centers for Disease Control and Prevention to identify patterns of COVID-19 immunity over time in previously and newly infected individuals. Dr. Jeff Burgess, associate dean for research and a professor at the Mel and Enid Zuckerman College of Public Health, is serving as principal investigator for the study, named the Arizona Healthcare, Emergency Response, and Other Essential Workers Surveillance, or AZ HEROES, Study.

Part of the virus that causes the illness Covid-19 could be used to help relieve pain, a new study suggests, by blocking the body’s pain pathway at a cellular level. Rajesh Khanna, a professor in the College of Medicine at the University of Arizona Health Sciences, and his research team found that the SARS-CoV-2 spike protein binds to neuropilin in exactly the same location as VEGF-A.

The new faculty cardiologists, Drs. Keng Pineda and Andrew Williams, bring expertise in interventional cardiology, cardiac imaging, cardio-oncology and sports cardiology to the University of Arizona Health Sciences and Banner – University Medicine Tucson.